BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14556661)

  • 1. Development of consensus fluorogenically labeled probes of the immunoglobulin heavy-chain gene for detecting minimal residual disease in B-cell non-Hodgkin lymphomas.
    Uchiyama M; Maesawa C; Yashima A; Tarusawa M; Satoh T; Ishida Y; Ito S; Murai K; Enomoto S; Utsugisawa T; Motoyoshi K; Masuda T
    Cancer Sci; 2003 Oct; 94(10):877-85. PubMed ID: 14556661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short consensus probes with 3'-minor groove binder of the immunoglobulin heavy-chain gene for real-time quantitative PCR in B-cell non-Hodgkin lymphomas.
    Uchiyama M; Maesawa C; Yashima-Abo A; Tarusawa M; Satoh M; Satoh T; Ishida Y; Ito S; Murai K; Enomoto S; Utsugisawa T; Masuda T
    Lab Invest; 2004 Jul; 84(7):932-6. PubMed ID: 15034598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
    Coupland SE; Hummel M; Müller HH; Stein H
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
    Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
    Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
    Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction.
    Yashima A; Maesawa C; Uchiyama M; Tarusawa M; Satoh T; Satoh M; Enomoto S; Sugawara K; Numaoka H; Murai K; Utsugisawa T; Ishida Y; Masuda T
    Leuk Res; 2003 Oct; 27(10):925-34. PubMed ID: 12860013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
    Zwicky CS; Maddocks AB; Andersen N; Gribben JG
    Blood; 1996 Nov; 88(9):3314-22. PubMed ID: 8896395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.
    Uchiyama M; Maesawa C; Yashima A; Itabashi T; Satoh T; Tarusawa M; Endo M; Takahashi Y; Sasaki S; Tsuchiya S; Ishida Y; Masuda T
    J Clin Pathol; 2003 Dec; 56(12):952-5. PubMed ID: 14645357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele-specific oligonucleotide real-time quantitative polymerase chain reaction.
    Tarusawa M; Yashima A; Endo M; Maesawa C
    Int J Hematol; 2002 Feb; 75(2):166-73. PubMed ID: 11939263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
    Böttcher S; Ritgen M; Pott C; Brüggemann M; Raff T; Stilgenbauer S; Döhner H; Dreger P; Kneba M
    Leukemia; 2004 Oct; 18(10):1637-45. PubMed ID: 15343348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus primers for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell lymphomas.
    Uchiyama M; Maesawa C; Yashima A; Itabashi T; Ishida Y; Masuda T
    J Clin Pathol; 2003 Oct; 56(10):778-9. PubMed ID: 14514784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphoma.
    Child FJ; Woolford AJ; Calonje E; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2001 Oct; 117(4):984-9. PubMed ID: 11676842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL.
    Chim JC; Coyle LA; Yaxley JC; Cole-Sinclair MF; Cannell PK; Hoffbrand VA; Foroni L
    Br J Haematol; 1996 Jan; 92(1):104-15. PubMed ID: 8562380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
    Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.
    Ben-Ezra J
    Leuk Lymphoma; 1992 Jul; 7(4):289-95. PubMed ID: 1493428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR.
    Brüggemann M; Droese J; Bolz I; Lüth P; Pott C; von Neuhoff N; Scheuering U; Kneba M
    Leukemia; 2000 Aug; 14(8):1419-25. PubMed ID: 10942238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved method for detection of B-lymphoid clonality by polymerase chain reaction.
    Deane M; McCarthy KP; Wiedemann LM; Norton JD
    Leukemia; 1991 Aug; 5(8):726-30. PubMed ID: 1909411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular diagnosis of non-Hodgkin B lymphomas by capillary electrophoresis and Genescan analysis: a molecular pathology laboratory experience].
    Donisi PM; Di Lorenzo N; Paparella A; Riccardi M; Stracca-Pansa V
    Pathologica; 2006 Apr; 98(2):139-46. PubMed ID: 16929787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.